Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making ...

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...

Affluent Medical recently announced agreements to acquire Caranx Medical and Artedrone to form a new medtech company called ...

Edwards Lifesciences Corp. received U.S. FDA approval for its Sapien M3 mitral valve replacement system, making it the first transcatheter therapy utilizing a transseptal approach to be indicated for ...

First-of-its-kind Edwards SAPIEN M3 transcatheter mitral valve system secures FDA approval for transseptal mitral ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

The MedTech industry has shown resilience and steady growth through 2025 while navigating lingering supply-chain issues, ...

Congenital heart disease (CHD) management has evolved substantially over recent decades, with transcatheter and hybrid interventions now providing minimally ...

The advent of transcatheter mitral valve repair (TMVr) and replacement (TMVR) has marked a revolutionary shift in the management of mitral valve disease, ...

AdventHealth Redmond is marking 50 years of advanced heart care, a milestone that traces its beginnings to the opening of ...